These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8932980)

  • 1. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero- 3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes.
    Cardile V; Jiang X; Renis M; Bindoni M
    Brain Res; 1996 Apr; 715(1-2):98-103. PubMed ID: 8739627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a).
    Kawano Y; Furukawa Y; Fukuda J; Matsumoto H; Yuge A; Narahara H
    Am J Reprod Immunol; 2007 Nov; 58(5):434-9. PubMed ID: 17922696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
    Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J
    Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 9. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
    Bennett SA; Birnboim HC
    Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
    Bazill GW; Dexter TM
    Cancer Res; 1990 Dec; 50(23):7505-12. PubMed ID: 2253199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR; Hoffman LH; Snyder F
    Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
    Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
    Borman RA; Jewell R; Hillier K
    Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.